ALAM KAMRAN (Chief Financial Officer) sold 6.6% of their position (102.82K shares) of TAYSHA GENE THERAPIES, INC. on the open market
Open‑market sale worth $485.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/27/2026ACC: 0001793412-26-000008
Officer· Chief Financial Officer
Since Sep 2020
-102.82K
Net shares
Net seller
$485.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
102.82K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−78.97K
Price / share
$4.75
Trade value
$375.10K
% of position
5.1%
1/23/2026
1.55M→1.47M
Common Stock
Direct
Shares
−23.85K
Price / share
$4.61
Trade value
$109.94K
% of position
1.6%
1/26/2026
1.47M→1.44M
Total
Net shares
−102.82K
Net value
-$485.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2026 | S · Sale | −78.97K | $4.75 | $375.10K | 5.1% | 1.55M | 1.47M |
| Common Stock Direct | 1/26/2026 | S · Sale | −23.85K | $4.61 | $109.94K | 1.6% | 1.47M | 1.44M |
| Total | −102.82K | -$485.04K | ||||||
Derivative Transactions0
No derivative transactions reported